Miami is a major pharmaceutical distribution hub, home to a dense network of retail chains, independent compounding pharmacies, and specialty pharmacies serving Miami-Dade's large elderly and medically complex population. When a drug reaches a patient defective in design, contaminated in manufacturing, inadequately labeled, or improperly compounded, the consequences can be severe, and the responsible parties extend from global manufacturers down to the local pharmacy counter.

Why Gold & Gold in Miami

Philip A. Gold and David H. Gold have pursued pharmaceutical injury cases involving both mass-tort prescription drugs and localized compounding pharmacy errors in the Miami-Dade market. From the Dadeland office, the firm coordinates with pharmacology experts and toxicologists, reviews FDA warning letters and 483 inspection reports, and identifies all liable parties in the distribution chain, from manufacturer to prescribing physician to the dispensing pharmacy.

Miami courts, deadlines & Florida rules

Pharmaceutical negligence claims in Florida include product liability (design defect, manufacturing defect, failure to warn), compounding pharmacy negligence under Florida Board of Pharmacy regulations, and prescriber malpractice. Under HB 837, the two-year statute of limitations applies to personal injury claims, though the discovery rule can extend the period when injury is latent. Compounding pharmacy claims are governed in part by Chapter 465, Florida Statutes and USP standards. The 51% comparative fault bar applies, and manufacturers frequently argue learned-intermediary defenses. Cases are filed in the 11th Judicial Circuit or, in mass-tort scenarios, may be coordinated in MDL proceedings in the Southern District of Florida.

Common pharmaceutical negligence cases we see in Miami

  • Contaminated compounded medications prepared at unlicensed or deficient Miami-area pharmacies
  • Failure-to-warn claims for prescription drugs widely prescribed to Miami-Dade's elderly population
  • Dispensing errors at high-volume retail pharmacies in Dadeland, Doral, and Hialeah
  • Recalled generic drugs distributed through South Florida wholesalers with undisclosed impurities
  • Adverse drug interactions resulting from a prescriber's failure to review a patient's medication history at UM Health or Baptist Health clinics
FAQ

Frequently Asked Questions

How do I know if my injury was caused by a defective drug or a compounding error?
A Gold & Gold investigation typically begins with a full review of your prescription records, pharmacy dispensing logs, and medical records from your treating physicians at Miami-area facilities. We then work with pharmacology experts to establish causation, connecting the specific drug lot, formulation, or labeling failure to your documented injury.
Can I join a national class action and still have Gold & Gold represent me locally?
In many pharmaceutical mass-tort cases, clients file individual claims within a federal MDL proceeding rather than a class action. Gold & Gold can represent you through that process, preserving your right to an individual damages assessment while benefiting from coordinated discovery at the national level.
Is there a time limit if I only recently discovered my injury was drug-related?
Florida's discovery rule can toll the two-year limitations period until you knew or reasonably should have known that the drug caused your injury. Because this analysis is fact-specific and the statute clock may already be running, contacting Gold & Gold promptly after any suspected drug injury is critical.